WEQUAL
8.11.2021 23:24:12 CET | Business Wire | Press release
Twenty-four women executives have been recognised by the WeQual Awards for their outstanding contribution to business from some of the biggest companies in the Europe, Middle East and Africa region. WeQual’s mission is to tackle the slow progress in appointing women to executive positions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211108006143/en/
Since its creation, more than 35% of the winners of previous WeQual Awards in the UK, EMEA, APAC and The Americas have already been promoted to the executive committees of major global companies.
The 24 WeQuals, all one level below Group ExCo or Group C-Suite leader, automatically become members of the WeQual Club. They join the 144 senior executives already enrolled. The winners in each category will be announced in January 2022.
The 24 WeQual Finalists for EMEA 2021:
Technology Category
- Cecile Bartenieff, COO of Global Banking & Investors Solutions and Global Head of Technology & Operations, Société Générale.
- Patricia Beau, Chief Technology Officer Lead / Partner For Consumer Healthcare, Sanofi.
- Miruna Senciuc, CEO, Romanian Branch, BNP Paribas Personal Finance.
Brand Category
- Mia Claselius, Vice President, Head of Communications, ABB Electrification, ABB Ltd.
- Noémie Ellezam, Group Chief Digital Strategy Officer, Société Générale.
- Anjana Srinivasan, Chief Operating Officer – HSBC Global Marketing, HSBC Holdings plc.
Transformation Category
- Naina Bhattacharya, Chief Information Security Officer, Danone.
- Christiane Lindenschmidt, Chief Digital and Data Officer, Markets and Securities Services, HSBC Holdings Plc.
- Chafika Chettaoui, Group Chief Data Officer, Suez.
Commercial Category
- Anne O'Leary, Chief Executive Officer, Vodafone Ireland, Vodafone Group Plc.
- Filipa Martins, Managing Director/CEO, Portugal, Edenred.
- Mieke De Schepper, Executive Vice President and Managing Director, Asia-Pacific, Amadeus IT Group.
Finance Category
- Anna Dimitrova, Chief Financial Officer and Strategy Director of Vodafone Germany
- Daria Dodonova, Chief Financial Officer, Magyar Telekom, Deutsche Telekom.
- Camila Japur, CFO Emerging Businesses, Ericsson.
Business Development Category
- Arancha Cordero, Chief Growth Officer Waters, Danone.
- Susan Uthayakumar, President, Sustainability Business Division, Schneider Electric.
- Bettina Möckel, Vice President Corporate Business Development, QIAGEN.
Procurement & Supply Chain Category
- Sigrid Brendel, Head of Global Procurement, CPO, Campari Group.
- Jessica Nordlinder, Chief Procurement Officer, Essity.
- Francesca Gamboni, Senior Vice President Global Supply Chain Groupe Stellantis, Stellantis.
People & Culture Category
- Audra Jenkins, Chief Diversity & Inclusion Officer, Randstad North America.
- Cecilia Hallengren, Senior Vice President, People and Culture, Volvo Group Trucks Technology, Volvo Group.
- Tina Mylon, SVP, Talent and Diversity, Schneider Electric.
Notes
Quotes available on request.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108006143/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corient Completes Acquisitions of Stonehage Fleming and Stanhope Capital Group; Global Assets Surpass US$500 Billion1.6.2026 08:15:00 CEST | Press release
Corient becomes the world’s largest non-bank wealth manager and multi-family office focused on serving ultra-high- and high-net-worth clients. Corient today announced the successful completion of its previously announced acquisitions of Stonehage Fleming and Stanhope Capital Group, marking a significant milestone in its continued global expansion. “This is an exciting moment for Corient and the clients we serve around the world,” said Kurt MacAlpine, Founding Partner and Chief Executive Officer of Corient. “We are thrilled to welcome our new Partners at Stonehage Fleming and Stanhope Capital Group to Corient as we continue building a truly global firm defined by partnership, collaboration and an unwavering commitment to client excellence.” With today’s announcement, Corient becomes the world’s largest non-bank wealth manager and multi-family office focused on ultra-high- and high-net-worth clients. The firm, established in 2020, operates under a client-first approach with complete fee
New Report From King: Mobile Games Sector Is Strategic Growth Driver for Europe, Contributing €6BN and Supporting 63,000+ Jobs1.6.2026 08:00:00 CEST | Press release
New report shows that more than 1,000 European mobile games studios contributed almost €6 billion to the European economy in 2025, supported more than 63,000 jobs1, and generated €7.53 billion in revenue from global audiences in 2025Mobile games are now the most popular way to play, accounting for 55% of global video games revenue, underlining their importance to Europe’s creative and digital economy King, the leading interactive entertainment company behind Candy Crush Saga, has today launched a first-of-its-kind report celebrating mobile games as a European success story,and spotlighting the sector’s contribution to jobs, growth, creativity and digital innovation across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260529376748/en/ The report,Mobile Matters: The Impact of Mobile Games for Europe, shows that in 2025 Europeanmobile games companies contributed an estimated €5.89 billion in economic value (GVA) to
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom